Synaptic Ventures
Overview
Synaptic Ventures is a venture capital firm dedicated to investing in early-stage companies within the life sciences and healthcare sectors. The firm aims to empower innovators by providing strategic financial guidance and unlocking global investment opportunities. Their investment approach is centered on identifying and supporting companies that have the potential to make significant impacts in the healthcare industry. The firm's investment strategy encompasses various stages, including Seed, Series A, and Series B funding, with investment sizes ranging from $1 million to $50 million. Synaptic Ventures has a global geographical focus, with investments in regions such as the United States, Singapore, China, India, Japan, South Korea, Australia, Germany, United Kingdom, France, Italy, Spain, Netherlands, Sweden, Norway, Denmark, Finland, Belgium, Switzerland, and Austria. This broad geographical reach allows the firm to tap into diverse markets and identify promising investment opportunities worldwide. Synaptic Ventures has a strong track record in the life sciences and healthcare sectors, having raised $50 million in 2024 and 2025 for life science companies. The firm has conducted due diligence on 151 companies since 2020, demonstrating its commitment to thorough evaluation processes. Additionally, Synaptic Ventures has achieved a 96% client satisfaction rate for three consecutive years, reflecting its dedication to delivering value to its portfolio companies. The firm's portfolio includes a biomanufacturing company founded in 2023, showcasing its involvement in innovative healthcare ventures.
Investment Focus
- Early-stage companies in the life sciences and healthcare sectors with innovative solutions and strong growth potential.
Reach Synaptic Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Synaptic Ventures
What sectors does Synaptic Ventures invest in?
Synaptic Ventures invests in Healthcare, Life Sciences, Healthcare Services, Digital Health, Pharmaceuticals and Medical Devices, and is based in Singapore. Synaptic Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does Synaptic Ventures invest at?
Synaptic Ventures backs companies at Seed, Early Stage, Series A and Series B, writing cheques of 1M - 50M.
Which regions does Synaptic Ventures invest in?
Synaptic Ventures invests across United States, United Kingdom, Germany, Japan, Australia and Singapore.
How do I contact Synaptic Ventures?
Synaptic Ventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database